Isabella Morrone

Isabella Morrone

Auto-generated profile, based on publicly available information

Isabella Morrone

Department of Geriatric and Internal Medicine, Reims University Hospitals, Maison Blanche Hospital, 51092 Reims, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2018 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
CBcoralie barbe
coralie barbe
DJDamien Jolly
Damien Jolly
IMIsabella Morrone
Isabella Morrone
ATAurore THIERRY
Aurore THIERRY
MDMoustapha Dramé
Moustapha Dramé
RMRachid MAHMOUDI
Rachid MAHMOUDI
Evaluation of health-related quality of life (HRQoL) in patients with Alzheimer’s disease (AD) is necessary to ensure optimal management. Several scales for assessing HRQoL of patients with AD exist, in particular the Quality of Life in Alzheimer’s Disease (QoL-AD), which includes an evaluation by the caregiver of the patient’s HRQoL. The aim of this study was to identify factors associated with patient, caregiver and overall HRQoL as assessed by the QoL-AD. Cross-sectional multicenter study in subjects aged 65 years and older, with mild to moderate AD. HRQoL scores from the QoL-AD were recorded (3 scores, corresponding to patient, caregiver and overall), as well as sociodemographic variables for the patient and the caregiver, and data from the geriatric cognitive assessment (cognitive, psycho-behavioral, functional evaluations). Caregiver burden was evaluated using the Zarit caregiver burden scale. Factors associated with each QoL-AD score were identified by multivariate linear regression using t-tests and β estimations. Study was registered in Clinical Trial.gov (NCT02814773). In total, 123 patients with AD were included. For the patient QoL-AD evaluation, depression was significantly associated with lower HRQoL (β = − 2.56 ± 1.28, p = 0.04), while polypharmacy (β = − 1.80 ± 0.99, p = 0.07) and anxiety (β = − 1.70 ± 1.01, p = 0.09) tended to be associated with lower HRQoL scores. In terms of caregiver evaluations, depression (β = − 3.46 ± 1.09, p = 0.002), polypharmacy (β = − 1.91 ± 0.92, p = 0.04) and the presence of caregiver burden (β = − 3.50 ± 0.91, p = 0.0002) were associated with lower HRQoL. For the overall evaluation, depression (β = − 3.26 ± 1.02, p = 0.002) and polypharmacy (β = − 1.85 ± 0.81, p = 0.03) were significantly related to lower HRQoL. Depression and polypharmacy were two factors influencing HRQoL in patients with AD, both by patient self-report and on the caregiver report. Thus, despite the discrepancies between HRQoL as assessed by patients with AD and HRQoL as assessed by their caregiver, the caregiver’s assessment may be used to guide patient management when the patient can no longer complete QoL evaluations. Moreover, the association between caregiver burden and the caregiver’s QoL-AD score underlines the need to take caregivers into consideration in the overall management of the AD patient.

1 September 2010 in Psychology and Aging
Verified
Journal Article
Closed access
IMIsabella Morrone
Isabella Morrone
CDChristelle Declercq
Christelle Declercq
JNJean-Luc Novella
Jean-Luc Novella
CBChrystel Besche
Chrystel Besche
The inhibitory deficit hypothesis has often been cited as a possible explanation for cognitive changes related to age. The aim of this study was to develop a new procedure for evaluating effortful inhibition on the basis of the comprehension of metaphors. Our experiment was carried out on younger and older adults, in whom we also measured inhibitory capacity, working memory, and processing speed. The results show that older participants required a longer time and made more frequent errors in rejecting metaphors versus literally false statements. The interference effect was predicted by the psychometric tests designed to evaluate inhibition.

14 January 2009 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
SVSaturnin Viatonou
Saturnin Viatonou
MDMoustapha Dramé
Moustapha Dramé
DJDamien Jolly
Damien Jolly
IMIsabella Morrone
Isabella Morrone
PLPierre Olivier Lang
Pierre Olivier Lang
JNJean‐Luc Novella
Jean‐Luc Novella

Verified
Journal Article
Open access
PDF file
RMRachid MAHMOUDI
Rachid MAHMOUDI
JNJean Luc Novella
Jean Luc Novella
SLSarah Laurent-Badr
Sarah Laurent-Badr
SBSarah Boulahrouz
Sarah Boulahrouz
DTDavid Tran
David Tran
YJYacine Jaïdi
Yacine Jaïdi
Cholinergic antagonists interfere with synaptic transmission in the central nervous system and are involved in pathological processes in patients with neurocognitive disorders (NCD), such as behavioral and psychological symptoms of dementia (BPSD). In this commentary, we will briefly review the current knowledge on the impact of cholinergic burden on BPSD in persons with NCD, including the main pathophysiological mechanisms. Given the lack of clear consensus regarding symptomatic management of BPSD, special attention must be paid to this preventable, iatrogenic condition in patients with NCD, and de-prescription of cholinergic antagonists should be considered in patients with BPSD.

1 June 2013 in European Geriatric Medicine
Verified
Journal Article
Closed access
MDMoustapha Dramé
Moustapha Dramé
RMRachid MAHMOUDI
Rachid MAHMOUDI
DJD. Jolly
D. Jolly
ARAmandine Rapin
Amandine Rapin
IMI. Morrone
I. Morrone
JNJ.-L. Novella
J.-L. Novella

30 March 2026
Verified
Thesis
Closed access
IMIsabella Morrone
Isabella Morrone
L'objectif de ce travail est de préciser le devenu des capacités d'identification, de mémorisation des émotions et d'évaluation de I' intensité des émotions avec l'avancée en âge, mais également lors de la survenue et de l'évolution de la démence de type Alzheimer (DTA). Notre travail s'inscrit dans le cadre des théories cognitives de l'évaluation et des modèles bidimensionnels des émotions prenant en compte la valence et l'intensité. Nous avons réalisé une pré-étude auprès de 42 adultes jeunes âgés de 20,74 ans (*1,75), afin de construire et valider notre matériel expérimental. Outre la valence émotionnelle (positive, négative et neutre), nous avons souhaité évaluer l'impact d'autres facteurs comme le contexte (items isolés versus items en contexte) et le type de présentation des items (verbal versus visuel versus auditif). Notre population d'études est composée de 4 groupes : 20 adultes jeunes âgés de 25,15 ans (i2,74), 20 adultes sains âgés de 74,5 ans (*5,21) [MMS=29,55 (I2,02)], 20 adultes présentant une DTA à un stade léger [MMS=24,2 (12,02)] figés de 77,5 ans (+6,04) et 20 adultes présentant une DTA à un stade modéré [MMS=18 (*1,34)] âgés de 77,85 ans (;t5,69). Nos principaux résultats permettent de retrouver dans le vieillissement cognitif normal et pathologique, la persistance de l'effet booster de la valence émotionnelle sur les capacités d'identification et de mémorisation, malgré la baisse progressive de ces capacités. Nous avons également mis en évidence la présence d'un effet de positivité sur les capacités d'identification et d'un effet de négativité sur les performances de mémorisation dans le vieillissement cognitif normal et qui perdure dans la DTA, quel que soit le degré de sévérité de la pathologie. Ces résultats sont discutés par rapport aux données de la Socioemotional Selectivity Theory de Carstensen (1993). Des pistes de prise en charge sont envisagées afin d'améliorer la qualité de vie des patients souffrant d'une DTA.